Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Colitis, Ulcerative × 30 days × Clear all

Status

Active not recruiting 1

Sponsor Class

OTHER 1 NIH 1 INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 231 Neoplasms 137 Breast Neoplasms 133 Colorectal Neoplasms 99 Prostatic Neoplasms 93 Neoplasm Metastasis 85 Ovarian Neoplasms 81 Multiple Myeloma 75 Melanoma 68 Lung Neoplasms 67 Endometrial Neoplasms 58 Recurrence 57 Stomach Neoplasms 55 Squamous Cell Carcinoma of Head and Neck 53 Pancreatic Neoplasms 50 Triple Negative Breast Neoplasms 44 Small Cell Lung Carcinoma 44 Leukemia, Myeloid, Acute 44 Leukemia, Lymphocytic, Chronic, B-Cell 44 Lymphoma, Non-Hodgkin 42 Lymphoma, Follicular 41 Lymphoma, Large B-Cell, Diffuse 39 Carcinoma, Renal Cell 38 Parkinson Disease 4, Autosomal Dominant Lewy Body 37 Urinary Bladder Neoplasms 35 Uterine Cervical Neoplasms 34 Myasthenia Gravis 33 Carcinoma, Hepatocellular 33 Lymphoma 30 Head and Neck Neoplasms 25

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02808780 2026-03-13

OPAL

Janssen Biotech, Inc.

Active not recruiting

Colitis, Ulcerative, Lymphoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡